/* Product view custom css */
Fresenius Kabi Oncology Limited

Fresenius Kabi Oncology Limited

Master

Fresenius Kabi Oncology Limited

Face Value 1
ISIN No INE575G01010

You can buy the below quantity from us by clicking on “Buy Now”
ID Face Value Quantity Rate Amount Mode Minimum Lot Size  
Currently there are no share available, for further details contact on 1800 209 2929 / 02267809990 / 09867572101 / 09987204585

Company Information

Fresenius Kabi Oncology Limited

BOARD OF DIRECTORS

Ms. Marla Gobbi, (Non Executive Chairperson)
Mr. Arvind Kumar Sharma, (Managing Director)
Mr. Nikhil Kulshreshtha, (Director & Company Secretary)
Dr. Michael Schonhofen, (Non Executive Director)
Mr. Steffen George Roser, (Non Executive Director)
Mr. Karsten Peter Lerch, (Non Executive Director)


BACKGROUND

Fresenius Kabi Oncology Ltd. ("the Company") a domestic public limited Company with registered office situated at B-310, Somdutt Chambers-1, Bhikhaji Cama Place, New Delhi. The company is the direct subsidiary of Fresenius Kabi (Singapore) Pte, a body Corporate incorporated in Singapore, which owns 97.05% stake in the company. The company belongs to group of a German pharmaceutical conglomerate named Fresenius SE & Co KGaA which is among leading players of generic products especially in Oncological sphere across the globe. It has two manufacturing facilities in the country, at Baddi, Himachal Pradesh and one at Kalyani, West Bengal. Company's Research & Development Centre is situated in the premises of Head Office. Exports to group companies constitute a significant share of annual turnover of the company.

REGISTERED OFFICE

B-310, Som Datt Chambers-I, Bhikaji Cama Place, New Delhi - 110 066 Tel.No.011-26105570


INCORPORATION YEAR

: 2003

WEBSITE

: http://www.fresenius-kabi-oncology.com

EMAIL

: corporatesecretarial.india@fresenius-kabi.com

CIN NO

: U24231DL2003PLC119441

ISIN NO.

: INE575G01010

SECTOR

: Pharmaceuticals

FACE VALUE

: 1

PROMOTER HOLDING

: 97.05%


FINANCIAL INFORMATION FOR LAST 2 YEARS (Rupees in Crore)

PARTICULARS

2019

2018

Equity Capital

17.024

17.024

Reserve & Surplus

389.82

441.15

Net Worth

406.84

458.17

Book Value Per Share

24

27

Total Income

701.449

734.37

Profit

-53.92

19.58

EPS Rs.

-3.16

1.15